Leptin and visfatin, which are involved in regulating endothelial function and NO-dependent vasorelaxation, have been proposed as clinical markers of endothelial dysfunction and vascular injury in cardiovascular diseases [15–17]. This evidence concerns the gene NAMPT and cardiovascular disorder.